SkylineDx is a pioneer in the field of molecular diagnostics through developing and commercializing innovative, signature-based diagnostics. Founded by Dharminder Chahal in 2005, SkylineDx is backed by investors that include Van Herk Ventures and is headquartered in Rotterdam.